Group 135

Biomarkers Profiling in Real-time

Mask Group
Mask Group-2

As the pursue of better patient healthcare continues, medical centers seek novel innovative technologies that can help reduce errors and increase standardization, leading ultimately to best treatment decisions for each patient.

Current patient diagnosis processes fail to identify all biomarkers, most are not tested in the standard of care. This is due to the dependence on adequate tissue to deliver conclusive results, and the costly and cumbersome process involved.

lmagene delivers a game-changing approach to oncology patient healthcare

We profile a broad range of biomarkers in real-time, with high sensitivity and specificity, no turnaround time or tissue dependencies.

Real-time Molecular Analysis

Immediate Biomarker Profiling


Image-based Only (no tissue required)


Accuracy Levels of Gold Standard Tests